You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

June 5, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Delay in filling clopidogrel prescription after coronary stent linked to adverse clinical outcomes

A delay in filling the first prescription for clopidogrel after coronary stenting is associated with an increased risk of death and myocardial infarction, according to a new study. » Full article

MERS, an interferon/innate immune deficiency state, continues to surge

The Middle East respiratory syndrome (MERS) is an infectious viral disease with about 30% mortality caused by viral pneumonia and associated lung damage. » Full article

Continuing Education

New CPE series: MTM Considerations for Adult Patients with CVD

Drug Topics kicks off a new CPE series, MTM Considerations for Adult Patients with Cardiovascular Disease, which will include 12 knowledge-based activities worth up to 24 credits. The goal of the first activity, “MTM essentials for cholesterol management,” will empower pharmacists to utilize current understanding of cholesterol management to improve patient care.

To read and print the article with TEST QUESTIONS, click here.
To proceed to the online exams and earn up to 2 CPE credits, click here to log in.


Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

 

Related Articles

FDA approves clot-busting vorapaxar

FDA approves new IV antibacterial drug used to treat adults with skin infections

RESOURCES

Latest Clinical News

EDITOR'S PICK

Screen high-risk people for hepatitis B: USPSTF

The US Preventive Services Task Force (USPSTF) is taking a stand on trying to reduce the incidence of hepatitis B (HBV) by recommending that individuals who are at high risk of infection should be screened.» Full article

Powered by Modern Medicine Advanstar Medical Communications Group